BBLG Bone Biologics: Operating Margin

Corporate emblem and logo of Bone Biologics Inc (BBLG)

Operating profitability reflects the profit dynamics of the core business, where the value 0.00 indicates the current figure. Bone Biologics (BBLG) develops advanced bone regeneration systems utilizing unique proteins. The issuer's revenues are based on the implementation of NELL-1 for spinal surgeries and fracture treatment. Surgeons highly value the company's clinical successes, while investors maintain cautious optimism.

BBLG: Bone Biologics Corp Operating Margin 07/04/2022 - 11/19/2026

Bone Biologics - analytical breakdowns and key metrics (BBLG)

- share price and consensus valuation forecast:
Fundamental company analysis:BBLG, Bone Biologics Corp.
Brand item of Bone Biologics Inc

Negative multiplier values often indicate an aggressive scaling phase, which is typical for high-tech startups. By analyzing the operating income as a percentage of revenue, an investor assesses the efficiency of the core business before financial expenses and taxes, where the current margin deficit of Bone Biologics (BBLG) is driven by colossal R&D costs and the patenting of the NELL-1 platform amid severe clinical risks.

Competitors of Bone Biologics (BBLG)

BSX (Boston Scientific Corporation Inc.) - Operating Margin|Operating Margin Edwards Lifesciences Inc.|Operating Margin RMD|Operating Sales Margin Insulet Corporation PODD|Operating Profitability Zimmer Biomet ZBH|CooperVision - Operating Profitability|ALGN - Operating Profitability|GMED: Operating Profitability|TMDX (TransMedics Corp) - Operating Sales Margin|Alphatec Holdings, Inc. - Operating Profit Rate|AORT (Artivion Corp) - Operating Margin|Operating Return on Sales Enovis Corp ENOV|Operating Profitability Integra LifeSciences Corp (IART)|Establishment Labs (ESTA) - Operating Profitability Margin|iLet Bionic Pancreas - Operating Sales Margin|Operating Margin IRADIMED CORPORATION IRMD|Embecta Corp - Operating Margin|Profitability of Operations Tandem Diabetes Care Inc TNDM|Axogen (AXGN) - Operating Profitability|Operating Profit Margin SIBN (SI-BONE Medical)|Operating Profitability orthofix.com|Operating Return on Sales bioventus.com BVS|Operating Margin KIDS|TMCI - Operating Return on Sales|Operating Profitability Strata Critical Medical Inc SRTA|CARL: Return on Sales by Operating Profit|RXST: Operating Sales Margin|clearpointneuro.com - Operating Profit Ratio|Stereotaxis Inc (STXS) - Operating Profitability|Return on Sales by Operating Profit STIM|SGHT (Sight Sciences Inc) - Operating Margin|OBIO: Operating Profit Rate|Operating Margin ANIK|Profitability of Operations inspiremd.com|Jin Medical International - Operating Sales Margin|Operating Margin Vivani Medical, Inc. VANI|XTNT: Operating Sales Margin|Operating Return on Sales NeuroOne Medical Technologies Corp.|MODD: Operating Margin|MYO - Profitability of Operations|Operating Profitability Envoy Medical Inc.|VVOS (Vivos Therapeutics, Inc.) - Operating Profit Ratio|Operating Sales Margin NVNO (enVVeno)|SINT - Operating Return on Sales|Operating Margin TNON (Tenon Medical)|ReWalk Robotics Ltd. (LFWD) - Operating Return on Sales|AMIX: Operating Sales Margin|IVF: Operating Profitability|AXNX: Operating Margin|Operating Sales Margin BIOLASE, Inc.|Operating Sales Margin DYNT|Operating Sales Margin Paragon 28 (FNA)|Operating Profitability INVO Bio (INVO)